Immunoassay News and Research RSS Feed - Immunoassay News and Research

BD launches new, wireless rapid diagnostic system for detection of flu, RSV and group A strep

BD launches new, wireless rapid diagnostic system for detection of flu, RSV and group A strep

BD (Becton, Dickinson and Company), a leading global medical technology company, today announced the launch of its next generation wireless rapid diagnostic system for detection of influenza A and B, respiratory syncytial virus (RSV) and group A strep, with new traceability and secure patient health record documentation features and functionality. [More]
Using biomarkers to diagnose sepsis: an interview with Jordi Trafi

Using biomarkers to diagnose sepsis: an interview with Jordi Trafi

Sepsis, according to the new clinical definition of sepsis, is organ dysfunction caused by the body’s dysregulated response to an infection. Sepsis is common, with about 20 million patients/year in the developed world. It can escalate to septic shock, which is a life-threatening condition with a mortality rate of about 40%. In fact, about every second someone in the world dies of sepsis. [More]
Penicillin allergy testing: an interview with Dr. Eric Macy

Penicillin allergy testing: an interview with Dr. Eric Macy

Penicillin was one of the first antibiotics developed and has saved millions of lives. First used in the early 1940s, penicillin is still one of the most widely used and least toxic family of antibiotics. [More]
New biochip test helps identify individuals at increased risk of Alzheimer's disease

New biochip test helps identify individuals at increased risk of Alzheimer's disease

Researchers today unveiled results from a new blood test to help identify which patients are at an elevated risk of Alzheimer's disease. [More]
Abingdon Health appoints JoyingBio as distributor of PCRD lateral flow immunoassays in China

Abingdon Health appoints JoyingBio as distributor of PCRD lateral flow immunoassays in China

Abingdon Health Ltd is pleased to announce the appointment of JoyingBio as distributor in China for PCRD nucleic acid lateral flow immunoassays (NALFIA). [More]

Abingdon Health declares FDA registration and CE marking of new ADxLR5 lateral flow device reader

Abingdon Health are pleased to announce the CE marking and FDA registration of their newly available immunoassay reader - ADxLR5 as a Class 1 Medical Device. [More]
Web Industries announces opening of new LFI production facility

Web Industries announces opening of new LFI production facility

Web Industries, Inc., innovative provider of precision contract manufacturing and converting services, is proud to announce the opening of the company's first lateral flow immunoassay (LFI) production facility. [More]
Surmodics introduces advanced immunoassay stabilizer StabilBlock

Surmodics introduces advanced immunoassay stabilizer StabilBlock

Surmodics, Inc., the global leader in chemical components for in vitro diagnostic (IVD) tests and microarrays, today announced the launch and immediate availability of StabilBlock, its most advanced Immunoassay Stabilizer. [More]
Free online World Sepsis Congress sponsored by Radiometer

Free online World Sepsis Congress sponsored by Radiometer

Radiometer is proud to announce that it is sponsoring the 1st World Sepsis Congress, from the 8th to the 9th of September 2016. Organized by the Global Sepsis Alliance, this free online event will give participants the chance to hear experts from around the world discuss the challenges and opportunities in the battle against this life-threatening illness. [More]
Novel enzyme immunoassay helps diagnose HCV infection in one simple step

Novel enzyme immunoassay helps diagnose HCV infection in one simple step

The current standard in diagnosing Hepatitis C virus (HCV) infection requires two sequential steps that make it suboptimal, costly, inconvenient, time consuming, and globally not widely available or affordable. [More]
New NICE guidance recommends use of Roche Diagnostics’ new pre-eclampsia test

New NICE guidance recommends use of Roche Diagnostics’ new pre-eclampsia test

Obstetricians and midwives are today welcoming the publication of new NICE guidance recommending the use of a new test from Roche Diagnostics that can rule-out the development of the life threatening condition, pre-eclampsia, within one week in pregnant women. [More]
Chromatrap re-designs website to better serve customer needs

Chromatrap re-designs website to better serve customer needs

Following extensive customer research, Chromatrap has re-designed its website to better serve the needs of end users. [More]
AMSBIO releases new practical guide that provides detailed overview on immunoassay blocking reagents

AMSBIO releases new practical guide that provides detailed overview on immunoassay blocking reagents

AMSBIO has released a new 16-page practical guide that provides a detailed overview on how blockers can be used to reduce non-specific binding in immunoassays. [More]
New device can deliver diagnosis to patient in 30 minutes

New device can deliver diagnosis to patient in 30 minutes

When a person contracts a disease, it takes time to diagnose the symptoms. Cell culturing, immunoassay and a nucleic-acid based diagnostic cycle all take several days, if not a week to determine the results. Not only do sick patients suffer during this time period, the wait can also lead to unnecessary disease spreading and perhaps avoidable antibiotic use. [More]
New ultra-sensitive technique shows promise as diagnostic tool for cancers, HIV

New ultra-sensitive technique shows promise as diagnostic tool for cancers, HIV

A common theme in medicine is that detecting a disease early on can lead to more effective treatments. This relies partly on luck that the patient gets screened at the right time, but more important is that the testing techniques are sensitive enough to register the minuscule hints that diseases leave in the blood stream. [More]
New biosensor test system developed for accurate measurements of protein molecule concentration in blood

New biosensor test system developed for accurate measurements of protein molecule concentration in blood

Researchers from the General Physics Institute of the Russian Academy of Sciences and Moscow Institute of Physics and Technology have developed a new biosensor test system based on magnetic nanoparticles. [More]

ProteinSimple expands Simple Plex immunoassay offering with launch of new single analyte cartridge

ProteinSimple announced today an expansion of the Simple Plex immunoassay offering by launching a new single analyte cartridge for the analysis of 72 samples at once. This new cartridge enables Simple Plex users to run 72 samples in an hour with triplicate results. It is powered by R&D Systems reagents, the expert in immunoassays. [More]
Beckman Coulter Access Family of Immunoassay Systems release new access TSH (3rd IS) Assay

Beckman Coulter Access Family of Immunoassay Systems release new access TSH (3rd IS) Assay

Beckman Coulter Diagnostics is pleased to announce obtaining CE Mark and the release of its new Access TSH (3rd IS) assay for use with the company’s Access Family of Immunoassay Systems. [More]
Advances in drug and alcohol testing: an interview with George Powell, President of Summit Diagnostics

Advances in drug and alcohol testing: an interview with George Powell, President of Summit Diagnostics

In the US, drug and alcohol testing has been a part of addiction and recovery for as long as I can remember. I started working in the business, basically in the employment industry, back in the mid-to-late 90s. Testing was essential, in that industries needed to ensure they had alcohol- and drug-free work places [More]
Roche files direct de novo application to FDA for Anti-Mullerian assay

Roche files direct de novo application to FDA for Anti-Mullerian assay

Roche announced today that it has filed a direct de novo application to the U.S. Food and Drug Administration for a fully automated Anti-Mullerian (AMH) assay for use on Roche's full portfolio of laboratory analyzers. The determination of AMH is useful for the assessment of ovarian reserve in women presenting to infertility clinics for evaluation in conjunction with other clinical and laboratory findings. [More]
Advertisement
Advertisement